Dr. David Ostransky, DO

Dr. Ostransky practices at North Texas Lung & Sleep Clinic PA in Southlake, Texas.

Dr. Ostransky's NPI, 1396710984, was assigned on February 17, 2006. Dr. Ostransky graduated from Kirksville College of Osteopathic Medicine in 1969. Dr. Ostransky holds Texas license G7561.

Dr. Ostransky's primary practice is North Texas Lung & Sleep Clinic PA, at 3071 W Southlake Blvd, Southlake, TX 76092 in Tarrant County. The practice phone is (817) 731-0230.

Dr. Ostransky's primary practice is North Texas Lung & Sleep Clinic PA in Southlake, Texas. Dr. Ostransky is also affiliated with Texas Health Fort Worth. The medical group on file is North Texas Lung and Sleep Clinic. Dmand AI also links Dr. Ostransky to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ostransky practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Ostransky's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Ostransky is board certified in 1980 - 1990 by the OH State License. Dr. Ostransky is licensed in Texas.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, hypersomnia and pneumonia among the conditions Dr. Ostransky treats.

CMS data shows 2,952 Medicare services from Dr. Ostransky across 17 procedure codes in 2024, for 1,282 Medicare patients. Medicare paid $279,291 for them. Every service was in an office.

CMS counts 1,282 Medicare patients who saw Dr. Ostransky in 2024. The largest group is 65 to 74, with 687 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ostransky's median patient age at 67, with 47% women.

In 2024, Dr. Ostransky wrote 6,870 Medicare Part D claims for 1,095 patients. 60% of them were for generic drugs. CMS names the drug for 6,608 of them, across 78 drugs with 11 or more claims each, at $2,253,661 in total drug cost. In 2023, CMS named 5,839 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ostransky for performance year 2024, reported as part of a group. Dr. Ostransky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ostransky as offering telehealth.

Dmand AI links 2 papers to Dr. Ostransky. Dr. Ostransky has published most often in J Am Osteopath Assoc. Dr. Ostransky's most frequent co-author is Evert Randall Bentley, DO.

Dmand AI links Dr. Ostransky to 1 clinical trial. Conditions studied include Sleep Apnea, Obstructive and Sleep Apnea Syndromes.

CMS Open Payments shows 492 general payments to Dr. Ostransky from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $119,319. It also lists 15 research payments totaling $86,180 from 2016 to 2017.

Dmand AI lists 2 awards for Dr. Ostransky, most recently CMS Stage 1 EHR in 2013.

Dr. Ostransky graduated from Kirksville College of Osteopathic Medicine in 1969. Dr. Ostransky is a member of AOA.

Dr. Ostransky is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.